Autolus Therapeutics plc Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Autolus Therapeutics plc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Autolus Therapeutics plc Return On Equity for the quarter ending June 30, 2024 was -66.8 %, a 2.9% decline year-over-year.
  • Autolus Therapeutics plc annual Return On Equity for 2023 was -106 %, a 67.9% decline from 2022.
  • Autolus Therapeutics plc annual Return On Equity for 2022 was -63 %.
  • Autolus Therapeutics plc annual Return On Equity for 2020 was -57.2 %, a 20.2% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -106 -42.8 -67.9% Jan 1, 2023 Dec 31, 2023
2022 -63 Jan 1, 2022 Dec 31, 2022
2020 -57.2 -9.62 -20.2% Jan 1, 2020 Dec 31, 2020
2019 -47.6 -24.9 -109% Jan 1, 2019 Dec 31, 2019
2018 -22.7 Oct 1, 2017 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.